Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inverness Finds New Revenue Stream Following Pfizer Settlement

This article was originally published in The Gray Sheet

Executive Summary

Inverness Medical's pregnancy test patent litigation settlement with Pfizer may lead to future collaborations between the firms related to the contended technology

You may also be interested in...



Pfizer, Inverness Agree To Work Together On Digital e.p.t. Pregnancy Test

Pfizer soon will sell a digital version of its e.p.t. pregnancy test kit under an agreement with Inverness Medical Innovations allowing the drug firm to use patented technology from Inverness' Clearblue Easy Digital product

Pfizer, Inverness Agree To Work Together On Digital e.p.t. Pregnancy Test

Pfizer soon will sell a digital version of its e.p.t. pregnancy test kit under an agreement with Inverness Medical Innovations allowing the drug firm to use patented technology from Inverness' Clearblue Easy Digital product

Inverness Expands Diagnostics Focus To Cardiac R&D

Inverness Medical Innovations plans to initiate a cardiac diagnostics portfolio with a home-use prothrombin test launch at the end of 2004

UsernamePublicRestriction

Register

LL010986

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel